Tamer Refaat, MD, PhD
Radiation Oncology
Speaks
Languages
Arabic
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
888-584-7888
Services & Specialties
Areas of Specialization
- Radiation Oncology
Clinical Interests
Conditions Treated
- pancreas cancer
- cholangiocarcinoma
- esophageal cancer
- gastroesophageal junction cancer
- gastrointestinal (gi) cancer
- colorectal malignancy
- anal cancer
- anorectal cancer
- intraoperative radiation therapy
- mri guided radiation therapy
- rectal cancer
- stereotactic body radiation therapy
- Breast Cancer
Locations & Contact
Primary Location
Loyola University Medical Center
2160 S First Ave
Maywood, IL 60153
Edward Hines Jr Veterans Administration Hospital
5000 S 5th Ave
5000 S 5th Ave
Hines, IL 60141
About
Academic Title
Professor
Leadership Title
Director of MRI-Guided Radiation Therapy
Director of IORT and MR-guided Radiation Therapy Programs
Director of Clinical Research
Director of International Outreach
Ages Seen
Additional Resources
Education & Certifications
Education
Education:
University of Alexandria
(2001)
Fellowship:
Northwestern University Feinberg School of Medicine
(2014)
Fellowship:
Northwestern University Feinberg School of Medicine
(2016)
Board Certifications
Radiation Oncology, Radiation Oncology, American Board of Radiology Subspecialty (2017)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Publications
- ACR Appropriateness Criteria® Staging and Follow-up of Anal Cancer. Expert Panel on Gastrointestinal Imaging; Horvat, N.; Liu, P. S.; Fowler, K. J.; Birkholz, J. H.; Cash, B. D.; Dane, B.; Eng, C.; Kambadakone, A. R.; Korngold, E. K.; Pietryga, J. A.; Refaat, T.; Santillan, C. S.; Surasi, D. S.; Woolsey, S.; Kim, D. H.; Journal of the American College of Radiology : JACR
- Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments. Thakkar, J. P.; Luy, D. D.; Pickles, A.; Refaat, T.; Prabhu, V. C.; Current neurology and neuroscience reports
- Current availability of radiotherapy devices in Peru and artificial intelligence-based analysis for constructing a nationwide implementation plan. Sarria, G. R.; Baldeon, D.; Payet, E.; Li, B.; Gkika, E.; Refaat, T.; Price, P.; Cordero, L.; Zubizarreta, E. H.; Sarria, G. J.; Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- Geometric and dosimetric evaluation for breast and regional nodal auto-segmentation structures. Tsui, T.; Podgorsak, A.; Roeske, J. C.; Small, W.; Refaat, T.; Kang, H.; Journal of applied clinical medical physics
- Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Siddiqui, A.; Ross, D.; Jani, R. H.; Prabhu, V. C.; Lo, S.; Wainwright, D. A.; Rouse, S.; Refaat, T.; Zhu, Y.; Thakkar, J. P.; Clinical & experimental neuroimmunology
- Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. Oladeru, O. T.; Dunn, S. A.; Li, J.; Coles, C. E.; Yamauchi, C.; Chang, J. S.; Cheng, S. H.; Kaidar-Person, O.; Meattini, I.; Ramiah, D.; Kirby, A.; Hijal, T.; Marta, G. N.; Poortmans, P.; Isern-Verdum, J.; Zissiadis, Y.; Offersen, B. V.; Refaat, T.; Elsayad, K.; Hijazi, H.; Dengina, N.; Belkacemi, Y.; Luo, F. D.; Lu, S.; Griffin, C.; Collins, M.; Ryan, P.; Larios, D.; Warren, L. E.; Punglia, R. S.; Wong, J. S.; Spiegel, D. Y.; Jagsi, R.; Taghian, A.; Bellon, J. R.; Ho, A. Y.; JCO global oncology
- Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma. Kutuk, T.; Walker, J. M.; Ballo, M. T.; Cameron, R. B.; Alvarez, J. B.; Chawla, S.; Luk, E.; Behl, D.; Dal Pra, A.; Morganstein, N.; Refaat, T.; Sheybani, A.; Squillante, C.; Zhang, J.; Kotecha, R.; Current oncology (Toronto, Ont.)
- Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients. Elsaka, R.; Kitagwa, J. M.; Refaat, T.; Mahmoud, A. A.; Shaikh, H.; Meheissen, M. A. M.; Elsaid, A. A.; American journal of clinical oncology
- Analytical dosimetric study of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for prostate cancer. Samir, F.; Meaz, T. M.; Hussiny, F. A.; Ahmed, A. A.; Mahmoud, A. A.; Refaat, T.; Gawish, A.; Abouegylah, M.; Journal of cancer research and clinical oncology
- Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments. Chuong, M. D.; Clark, M. A.; Henke, L. E.; Kishan, A. U.; Portelance, L.; Parikh, P. J.; Bassetti, M. F.; Nagar, H.; Rosenberg, S. A.; Mehta, M. P.; Refaat, T.; Rineer, J. M.; Smith, A.; Seung, S.; Zaki, B. I.; Fuss, M.; Mak, R. H.; Clinical and translational radiation oncology
- Intraoperative radiation therapy for locally advanced and recurrent head and neck cancer. Chiodo, C.; Gros, S.; Emami, B.; Lee, B.; Block, A.; Sethi, A.; Small, W.; Refaat, T.; Molecular and clinical oncology
- The case for risk-stratified IORT for early breast cancer. Refaat, T.; Gros, S. E.; Small, W.; Brachytherapy
- Risk-Stratified Intraoperative Radiation Therapy as a Definitive Adjuvant Radiation Therapy Modality for Women With Early Breast Cancer. Small, W.; Refaat, T.; Feldman, S. M.; Holmes, D.; Practical radiation oncology
- Impact of Race and Health Insurance Status on Response to Neoadjuvant Chemotherapy for Breast Cancer Patients. Ho, Y.; Harris, A.; Wesolowski, M.; Refaat, T.; Small, W.; Thomas, T. O.; Cureus
- Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy. Gaber, G.; El Achy, S.; Khedr, G. A.; Parimi, V.; Helenowksi, I.; Donnelly, E. D.; Strauss, J. B.; Woloschak, G.; Wei, J. J.; Small, W.; Refaat, T.; American journal of clinical oncology
- Prognostic Significance of Nuclear Factor Kappa B Expression in Locally Advanced Cervical Cancer Patients Treated Definitively With Concurrent Chemoradiation. Altoos, B.; Small, C.; Dalal, P.; Attieh, D.; El Achy, S.; Parimi, V.; Wei, J. J.; Helenowski, I.; Donnelly, E. D.; Strauss, J.; Small, W.; Refaat, T.; American journal of clinical oncology
- Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer. Petras, K. G.; Rademaker, A. W.; Refaat, T.; Choi, M.; Thomas, T. O.; Pauloski, B. R.; Mittal, B. B.; Radiation oncology (London, England)
- Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity. Refaat, T.; Donnelly, E. D.; Gentile, M.; Novak, C.; Yuan, Y.; Khedr, G. A.; Helenowksi, I.; Lurain, J.; Schink, J.; Rademaker, A.; Sathiaseelan, V.; Strauss, J. B.; Small, W.; American journal of clinical oncology